They pointed out that BMI can classify some people with a “normal” BMI, even when they have a high percentage of body fat. A ...

New Delhi: India plans to roll-out a nationwide screening programme for measuring obesity among school children officials aware of the matter said. Children will be measured for their waist-to-hip ...

A novel oral peptide PN-477o with once-daily dosing, high potency and activation of glucagon-like peptide-1 (GLP-1), ...

Discover how smoking during pregnancy may increase childhood obesity risk, according to new research from Washington State ...

China NMPA approves Innovent’s mazdutide, first dual GCG/GLP-1 receptor agonist for chronic weight management: San Francisco, US Monday, June 30, 2025, 12:00 Hrs [IST] Innovent ...

Reformulation is back on the agenda, with all big food businesses in the UK coming clean on their healthy vs unhealthy sales ...

Supermarkets will be forced to incentivise customers to swap certain foods for healthier versions - but experts say it’s ...

Unlike GLP-1s, which reduce both fat and lean mass, SKNY-1 demonstrated significant ... The study was conducted in an obesity and craving model in Ob42 Strain-mc4r (G894C) mutated zebrafish following ...

We have witnessed weight loss of 13–15% with the glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide and up to 18–23% with the dual GLP-1/glucose-dependent insulinotropic polypeptide (GIP) ...

California aims to eliminate ultra-processed foods from schools by 2035, driven by health concerns and bipartisan support.

Mounjaro offers up to 20% weight loss – but it’s not for everyone. Learn about eligibility, alternatives and why long-term ...

MIRA READ THE FULL MIRA RESEARCH REPORT MIRA Pharmaceuticals (NASDAQ:MIRA) is a clinical-stage pharmaceutical company focused on the development and commercialization of a new molecular synthetic ...